{"id":111469,"date":"2026-08-26T09:45:10","date_gmt":"2026-08-26T07:45:10","guid":{"rendered":"http:\/\/zzzconmedia.zierra.de\/?p=111469"},"modified":"2026-08-26T09:45:10","modified_gmt":"2026-08-26T07:45:10","slug":"bionxt-erreicht-wichtigen-meilenstein-im-klinischen-cladribin-programm-fur-ms-mit-abschluss-des-impd-vor-beginn-der-klinischen-studien-am-menschen","status":"publish","type":"post","link":"https:\/\/conmedia.org\/?p=111469","title":{"rendered":"BioNxt erreicht wichtigen Meilenstein im klinischen Cladribin-Programm f\u00fcr MS mit Abschluss des IMPD vor Beginn der klinischen Studien am Menschen"},"content":{"rendered":"<p>Vancouver, BC, 26.08.2026 (PresseBox) &#8211; BioNxt Solutions Inc. (\u201eBioNxt\u201c oder das \u201eUnternehmen\u201c) (CSE:BNXT)(OTCQB:BNX\u00adTF)(FWB:BXT), ein innovatives Biowissenschaftsunte\u00adrnehmen, das sich auf fortschrittliche&#8230;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Vancouver, BC, 26.08.2026 (PresseBox) &#8211; BioNxt Solutions Inc. (\u201eBioNxt\u201c oder das \u201eUnternehmen\u201c) (CSE:BNXT)(OTCQB:BNX\u00adTF)(FWB:BXT), ein innovatives Biowissenschaftsunte\u00adrnehmen, das sich auf fortschrittliche&#8230;<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-111469","post","type-post","status-publish","format-standard","hentry","category-allgemein"],"acf":[],"_links":{"self":[{"href":"https:\/\/conmedia.org\/index.php?rest_route=\/wp\/v2\/posts\/111469","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/conmedia.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/conmedia.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/conmedia.org\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/conmedia.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=111469"}],"version-history":[{"count":0,"href":"https:\/\/conmedia.org\/index.php?rest_route=\/wp\/v2\/posts\/111469\/revisions"}],"wp:attachment":[{"href":"https:\/\/conmedia.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=111469"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/conmedia.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=111469"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/conmedia.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=111469"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}